However, in patients with mild to moderate renal impairment (GFR ≥ 30 ml/ min/ 1.73 m2 but < 60 ml/ min/ 1.73 m2), Rasilez HCT should be administered with caution.
Tuttavia, nei pazienti con insufficienza renale da lieve a moderata (GFR ≥ 30 ml/ min/ 1,73 m2 ma < 60 ml/ min/ 1,73 m2), Rasilez HCT deve essere somministrato con cautela.